Rabbit Anti-Armenian Hamster IgG H&L (HRP) (ab5745)

製品の概要

  • 製品名
    Rabbit Anti-Armenian Hamster IgG H&L (HRP)
    IgG 二次抗体 製品一覧
  • 製品の詳細
    Rabbit polyclonal Secondary Antibody to Armenian Hamster IgG - H&L (HRP)
  • ターゲット生物種
    Armenian hamster
  • 特異性
    Assay by immunoelectrophoresis resulted in a single precipitin arc against anti-Peroxidase, anti-Rabbit Serum, Armenian Hamster IgG and Armenian Hamster Serum.
  • アプリケーション
    適用あり: ICC/IF, Dot blot, WB, ELISA, Electron Microscopy, IHC-Pmore details
  • 免疫原

    Armenian Hamster IgG whole molecule.

  • 標識
    HRP

製品の特性

  • 製品の状態
    Liquid
  • 保存方法
    Shipped at 4°C. Store at +4°C.
  • バッファー
    Preservative: 0.01% Gentamicin Sulfate
    Constituents: 10mg/ml BSA (IgG and protease free), 0.15M Sodium Chloride, 0.02M Potassium Phosphate. pH 7.2
  • Concentration information loading...
  • 特記事項(精製)
    This product was prepared from monospecific antiserum by immunoaffinity chromatography using Armenian Hamster IgG coupled to agarose.
  • 特記事項(標識)
    Horseradish Peroxidase (HRP).
  • ポリ/モノ
    ポリクローナル
  • アイソタイプ
    IgG
  • 研究分野

アプリケーション

Our Abpromise guarantee covers the use of ab5745 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

アプリケーション Abreviews 特記事項
ICC/IF 1/1000 - 1/5000.
Dot blot Use at an assay dependent dilution.
WB 1/1000 - 1/5000.
ELISA 1/25000. This product has been assayed against 1.0 ug of Armenian Hamster IgG in a standard capture ELISA using ABTS (2,2’-azino-bis-[3-ethylbenthiazoline-6-sulfonic acid]) as a substrate for 30 minutes at room temperature.
Electron Microscopy Use at an assay dependent dilution.
IHC-P 1/1000 - 1/5000.

Rabbit Anti-Armenian Hamster IgG H&L (HRP) (ab5745) 使用論文

This product has been referenced in:
  • Bianchi R  et al. Mutation of Threonine 34 in Mouse Podoplanin-Fc Reduces CLEC-2 Binding and Toxicity in Vivo While Retaining Anti-lymphangiogenic Activity. J Biol Chem 289:21016-21027 (2014). Read more (PubMed: 24907275) »
  • Woessner DW & Lim CS Disrupting BCR-ABL in combination with secondary leukemia-specific pathways in CML cells leads to enhanced apoptosis and decreased proliferation. Mol Pharm 10:270-7 (2013). Read more (PubMed: 23211037) »

See all 3 Publications for this product

Product Wall

Thanks for your message and for kindly providing this further information.

I have copied below the IHC-P testing protocol for this antibody, which includes the antigen retrieval details. I hope this will be helpful. Please note this protocol...

Read More

Thank you for taking the time to complete our questionnaire and contact us. I am sorry to hear you have had difficulty obtaining satisfactory results from this antibody.

The details you have kindly provided will enable us to investigate this...

Read More

Vielen Dank für Ihre Anrufe.
Wie besprochen können wir den MCP1 Antikörper für Western blot und Durchflußzytometrie garantieren (www.abcam.com/Abpromise). In der Immuncytochemie/Immunfluoreszenz (ICC/IF) wurde er noch nicht getestet, aber es beste...

Read More

Thank you for your enquiry. This product ab36772 was created by immunizing Armenian hamsters with a synthetic peptide conjugated to KLH. The resulting splenocytes were then fused to the tumor cell line SP2/0. We recommend using any HRP conjugat...

Read More

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

登録